TOCCI, GIULIANO
 Distribuzione geografica
Continente #
NA - Nord America 8.660
EU - Europa 2.023
AS - Asia 1.248
AF - Africa 105
SA - Sud America 63
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.104
Nazione #
US - Stati Uniti d'America 8.571
IT - Italia 897
SG - Singapore 442
IN - India 426
CN - Cina 325
SE - Svezia 317
FI - Finlandia 197
DE - Germania 141
UA - Ucraina 130
IE - Irlanda 89
CA - Canada 82
TG - Togo 80
GB - Regno Unito 60
AR - Argentina 43
BG - Bulgaria 42
FR - Francia 40
RO - Romania 29
BE - Belgio 26
NL - Olanda 24
TR - Turchia 14
BR - Brasile 12
ZA - Sudafrica 10
ID - Indonesia 7
JP - Giappone 6
ES - Italia 5
PE - Perù 5
PH - Filippine 5
AU - Australia 4
CH - Svizzera 4
PK - Pakistan 4
RU - Federazione Russa 4
VN - Vietnam 4
CL - Cile 3
MX - Messico 3
PT - Portogallo 3
RS - Serbia 3
AL - Albania 2
AM - Armenia 2
AT - Austria 2
CM - Camerun 2
CR - Costa Rica 2
EG - Egitto 2
HK - Hong Kong 2
HU - Ungheria 2
IL - Israele 2
KR - Corea 2
KZ - Kazakistan 2
MQ - Martinica 2
SC - Seychelles 2
SI - Slovenia 2
TZ - Tanzania 2
UG - Uganda 2
BY - Bielorussia 1
EU - Europa 1
GH - Ghana 1
GN - Guinea 1
IR - Iran 1
LT - Lituania 1
LU - Lussemburgo 1
ML - Mali 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
PL - Polonia 1
SA - Arabia Saudita 1
SN - Senegal 1
TW - Taiwan 1
Totale 12.104
Città #
Fairfield 1.620
Ashburn 752
Woodbridge 751
Seattle 632
Houston 585
Cambridge 523
Wilmington 490
Chandler 422
Ann Arbor 292
Singapore 272
Princeton 270
Rome 235
San Paolo di Civitate 226
Dearborn 199
Lawrence 184
Plano 175
Beijing 133
Boston 116
San Diego 114
Millbury 108
Dublin 82
Lomé 80
Andover 64
Ottawa 54
Helsinki 52
Federal 42
Jacksonville 42
New York 42
Sofia 42
Norwalk 38
Milan 36
Fremont 35
Falls Church 34
Santa Clara 31
Boardman 28
Nanjing 24
Toronto 23
Bühl 21
Guangzhou 21
Hefei 21
Kunming 20
Washington 19
Fasano 18
Mannheim 15
Brussels 12
Des Moines 12
Istanbul 12
Jinan 12
Liège 12
Florence 11
Nanchang 9
Pontassieve 9
Redwood City 9
San Mateo 9
Poggibonsi 8
Catania 7
Hebei 7
Lappeenranta 7
London 7
Los Angeles 7
Southend 7
Tarzo 7
Auburn Hills 6
Bari 6
Buffalo 6
Cagliari 6
Changsha 6
Medolla 6
Muizenberg 6
Phoenix 6
Albano Laziale 5
Ancona 5
Brescia 5
Hyderabad 5
Montréal 5
Mumbai 5
Padova 5
Redmond 5
Wuhan 5
Campo Grande 4
Chengdu 4
Cornate D'adda 4
Durham 4
Fuzhou 4
Ladispoli 4
Laurel 4
Nellore 4
Paris 4
Pune 4
Sacramento 4
Shanghai 4
Terni 4
Xian 4
Amsterdam 3
Bremen 3
Clichy 3
Columbus 3
Dallas 3
Denpasar 3
Domont 3
Totale 9.317
Nome #
Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage 114
Effects of different statin types and dosages on systolic/diastolic blood pressure. Retrospective analysis of 24-hour ambulatory blood pressure database 103
Prediction of Long-Term Survival in Chronic Heart Failure by Multiple Biomarker Assessment: A 15-Year Prospective Follow-Up Study 98
Managing hypertension in cardiology practice according to risk profile. 97
Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention. analysis of a large real practice database in Italy 94
24-Hour ambulatory blood pressure levels and control in a large cohort of adult outpatients with different classes of obesity 90
A survey on blood pressure levels and hypertension control in a sample of the italian general population 89
Development of heart failure in recent hypertension trials. 89
P-Wave Duration in Lead aVR and the Risk of Atrial Fibrillation in Hypertension. 87
Cardiovascular risk and hypertension control in Italy. Data from the 2015 World Hypertension Day 87
Angiotensin II receptor blocker neprilysin inhibitor (ARNI). new avenues in cardiovascular therapy 86
Achievement of multiple therapeutic targets for cardiovascular disease prevention. Retrospective analysis of real practice in Italy 85
Early cardiac abnormalities and increased C-reactive protein levels in a cohort of children with sleep disordered breathing 84
Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian Society of Hypertension 84
Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials 83
Increased arterial stiffness and haemorrhagic transformation in ischaemic stroke after thrombolysis: A new marker of risk for cerebrovascular events and complications 83
Prevalence and clinical outcomes of white-coat and masked hypertension: analysis of a large ambulatory blood pressure database 83
Nocturnal blood pressure patterns and cardiovascular outcomes in patients with masked hypertension 82
Therapeutic Approach to Hypertension Urgencies and Emergencies During Acute Coronary Syndrome 81
Antihypertensive strategy based on angiotensin II receptor blockers: A new gateway to reduce risk in hypertension 80
Olmesartan medoxomil for the treatment of hypertension in children and adolescents 79
Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter? 79
Oxidative stress and cardiovascular disease 79
Hypertension in the elderly. Which are the blood pressure threshold values? 79
End-Organ Protection in Patients with Hypertension Focus on the Role of Angiotensin Receptor Blockers on Renal Function 78
Pathophysiology of biventricular dysfunction during hemodialysis: Emerging concepts 77
Antihypertensive Therapy in Diabetes: The Legacy Effect and RAAS Blockade 77
2007 ESH/ESC Guidelines for the management of hypertension, from theory to practice: global cardiovascular risk concept. 77
Evaluation of Systolic Properties in Hypertensive Patients With Different Degrees of Diastolic Dysfunction and Normal Ejection Fraction 76
Ambulatory blood pressure and arterial stiffness web-based telemonitoring in patients at cardiovascular risk. First results of the VASOTENS (Vascular health ASsessment Of The hypertENSive patients) Registry 76
Challenging hypertension: How to diagnose and treat resistant hypertension in daily clinical practice 76
Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome 75
Adding markers of organ damage to risk score models improves cardiovascular risk assessment: prospective analysis of a large cohort of adult outpatients 75
Antihypertensive drugs and the risks of cancer: more fakes than facts 75
Effect of resveratrol on blood pressure: a systematic review and meta-analysis of randomized, controlled, clinical trials 74
Fewer mega-trials and more clinically oriented studies in hypertension research? The case of blocking the renin-angiotensin-aldosterone system. 74
Hypertension in Young People. Epidemiology, Diagnostic Assessment and Therapeutic Approach 74
A novel electrocardiographic T-Wave measurement (Tp-Te Interval) as a predictor of heart abnormalities in hypertension: a new opportunity for first-line electrocardiographic evaluation 72
Hypertension and heart failure: role of neurohormonal mechanisms. 72
Single blind, multicentre, randomized, controlled trial testing the effects of a novel nutraceutical compound on plasma lipid and cardiovascular risk factors. Results of the interim analysis 72
Nation-wide hypertension screening in italy. data from may measurements month 2017-europe 72
Predictive Role of High Blood Pressure for the Incidence of Metabolic Syndrome 71
A review of angiotensin receptor blocker-based therapies at all levels of cardiovascular risk 71
Fixed-combination therapies in hypertension management: Focus on enalapril/lercanidipine 70
The clinical relevance of dysfunctional HDL in patients with coronary artery disease: A 3-year follow-up study 70
Blood pressure control in Italy: results of recent surveys on hypertension 70
Upcoming challenges for training in cardiology 70
Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000-2005 and 2005-2011 hypertension surveys. 70
Tp-Te interval predicts heart rate reduction after fingolimod administration in patients with multiple sclerosis 69
Management of hypertension and stroke prevention: Results of the Italian cardiologist survey 68
The reduction of NDUFC2 expression is associated with mitochondrial impairment in circulating mononuclear cells of patients with acute coronary syndrome 68
Xanthine oxidase inhibitors in elderly patients with heart failure. useful or useless? 68
Abnormal regulation of renin angiotensin aldosterone system is associated with right ventricular dysfunction in hypertension 68
Calcium Channel Blockers and Hypertension. 67
Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass 67
Hypertension Across the Atlantic. A Sprint or a Marathon? 67
Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic 67
Serum uric acid and other short-term predictors of electrocardiographic alterations in the Brisighella Heart Study cohort 67
Use of fixed combination therapies to improve blood pressure control in the clinical management of hypertension: a key opportunity 66
Clinical management of patients with hypertension and high cardiovascular risk in specialised centers and in general practice. Analysis from an Italian Survey Questionnaire 66
Prevalence and control of hypertension in the general practice in Italy: updated analysis of a large database 66
Redefining Blood Pressure Targets in High-Risk Patients?: Lessons From Coronary Endpoints in Recent Randomized Clinical Trials 66
Reclassification of Hypertensive Outpatients According to New US Guidelines on High Blood Pressure 66
Prevalence and correlates of echocardiographic left atrial enlargement in hypertensive outpatients in clinical practice 65
null 65
Is early and fast blood pressure control important in hypertension management? 65
Immigration emergency in Italy. The impact of socioeconomic status on blood pressure levels and control 65
Legacy effect in the treatment of hypertension: persistent cardiovascular protection after conclusion of randomized clinical trials in hypertension 65
Trehalose, a natural disaccharide, reduces stroke occurrence in the stroke-prone spontaneously hypertensive rat 65
An analysis of the management of cardiovascular risk factors in routine clinical practice in Italy: An overview of the main findings of the EFFECTUS study 64
Right ventricular dysfunction in patients with end-stage renal disease 64
Use of fixed-dose combinations in hypertension and cardiovascular disease prevention 64
Association of renal damage with cardiovascular diseases is independent of individual cardiovascular risk profile in hypertension: data from the Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study 64
Search of multiple markers of organ damage for better cardiovascular risk stratification in hypertension. Role of “SHATS” syndrome in the clinical practice 63
ARB-based combination therapy for the clinical management of hypertension and hypertension-related comorbidities: a spotlight on their use in COVID-19 patients 63
National survey on excellence centers and reference centers for hypertension diagnosis and treatment: Geographical distribution, medical facilities and diagnostic opportunities 62
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 62
Blockade of the neurohormonal systems in heart failure with preserved ejection fraction. A contemporary meta-analysis 62
Renin-angiotensin system blockers increase risk of angio-oedema. 61
Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis 61
Angiotensin II receptor blockers and coronary artery disease: 'presumed innocents'. 61
Influence of anti-TNF immunogenicity on safety in rheumatic disease. a narrative review 61
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials 60
Time trend analysis of hypertension prevalence, awareness, treatment and control in Italy. novel insights from recent national surveys in the general population 60
null 60
Conventional and new electrocardiographic criteria for hypertension-mediated cardiac organ damage. A narrative review 59
White-coat and masked hypertension and coronary artery disease. are they related or not? 59
Impact of physicians' age on the clinical management of global cardiovascular risk: analysis of the results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitisation Educational Programme. 59
Hypertension and cardiovascular risk: The importance of a global approach to risk management in the light of current hypertension guidelines 58
Exploration into uric and cardiovascular disease. uric acid right for heArt health (urrah) project, a study protocol for a retrospective observational study 58
Do diabetes, metabolic syndrome or their association equally affect biventricular function? A tissue Doppler study 58
Implications of guidelines for hypertension management in europe. 58
Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis 58
Impact of Diabetes Mellitus on the Clinical Management of Global Cardiovascular Risk: Analysis of the Results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitization (EFFECTUS) Educational Program 57
Use of predictive markers to improve cardiovascular protection 57
Educational interventions may promote better blood pressure control in Russia 57
Metabolic approaches to antihypertensive treatment in diabetic patients 57
Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O-2(-) production 57
Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. 56
null 56
Totale 7.111
Categoria #
all - tutte 41.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.695


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.770 0 0 38 138 299 524 524 382 415 224 130 96
2020/20211.140 168 117 82 66 51 77 25 127 130 120 117 60
2021/20222.405 46 140 262 99 318 53 98 258 168 173 376 414
2022/20232.121 461 575 88 147 206 149 45 114 188 33 70 45
2023/20241.328 60 172 93 130 102 157 47 93 26 167 136 145
2024/2025375 74 174 127 0 0 0 0 0 0 0 0 0
Totale 12.752